Osmosis Investment Management UK »

United Therapeutics Corporation shares owned by Osmosis Investment Management UK

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Osmosis Investment Management UK from 13F filings

Historical chart of Osmosis Investment Management UK investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Osmosis Investment Management UK consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Osmosis Investment Management UK

Quarter filed Position value Share count Share price at filing
2026-03-31 $956k 1.6k 592.98

More positions owned by Osmosis Investment Management UK

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Astrazeneca Ord (AZN)
Coca-Cola Company (KO)
Bristol Myers Squibb (BMY)

View all positions for Osmosis Investment Management UK

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Renaissance Technologies
Geode Capital Management
Caption Management
Henderson Group
Susquehanna International
AQR Capital Management
Citadel Advisors
Assetmark

View all funds holding United Therapeutics Corporation